NAD+ 100 mg + MOTS-c 10 mg + 5-Amino-1MQ 10 mg. Work out exactly what to draw for your own mix, see the doses used in research, and follow a week-by-week plan. Evidence tier: preclinical.
The studies behind this compound did not test timing or food state as variables, so we are not going to invent a rule. Pick a time you can keep to consistently.
| When | Dose | How Often | How Many mL | Draw To | Number Of Doses | Peptide Used |
|---|---|---|---|---|---|---|
| Weeks 1–2 | 3 mg | daily | 0.075 mL | 7.5 u | 14 | 42 mg |
| Weeks 3–4 | 6 mg | daily | 0.15 mL | 15 u | 14 | 84 mg |
| Weeks 5–6 | 9 mg | daily | 0.225 mL | 22.5 u | 14 | 126 mg |
| Week 7 onward per 4 weeks from here on |
12 mg | daily | 0.3 mL | 30 u | 28 | 336 mg |
| Level | Dose | How Often | How Many mL | Draw To | Doses In Vial |
|---|---|---|---|---|---|
| Week 1–2 start | 3 mg | 1× daily (0.25 mg MOTS-c / 2.5 mg NAD+) | 0.075 mL | 7.5 u | 40 doses |
| Week 3–4 | 6 mg | 1× daily (0.5 mg MOTS-c / 5 mg NAD+) | 0.15 mL | 15 u | 20 doses |
| Week 5–6 | 9 mg | 1× daily (0.75 mg MOTS-c / 7.5 mg NAD+) | 0.225 mL | 22.5 u | 13 doses |
| Target | 12 mg | 1× daily (1 mg MOTS-c / 10 mg NAD+) | 0.3 mL | 30 u | 10 doses |
A metabolic combination in a 120 mg vial, dosed daily and anchored to MOTS-c. MOTS-c is 8.3% of the contents, so a 1 mg daily MOTS-c dose means 12 mg of blend — which also delivers 10 mg of NAD+ and 1 mg of 5-Amino-1MQ. Because the ratio is fixed, anchoring to MOTS-c puts the other two low against their own figures: NAD+ is reported at 50–100 mg per dose and 5-Amino-1MQ at 2.5–5 mg. At 1 mg MOTS-c daily a vial runs about 10 days.
Buy Mito BlendPaid affiliate links.
Adding 3 mL of bacteriostatic water to a 120 mg vial gives 40 mg/mL. That is the mix every number on this page is worked out from — change the water figure in the calculator and all the draw amounts update.
Published and reported figures for Mito Blend run from 3 mg to 12 mg, typically 1× daily (0.25 mg MOTS-c / 2.5 mg NAD+). This site lists each figure with the source it came from rather than giving a single recommended number.
At 40 mg/mL, a 3 mg dose is 7.5 units on a 1 mL U-100 insulin syringe. One vial at that mix gives about 40 doses.
Mito Blend is graded preclinical. Laboratory and animal data only. No human dosing trials have been published. We grade every compound on this site so you can weigh the numbers accordingly — the full method is on our editorial policy page.
Yes — Build up to 1 mg MOTS-c daily. The week-by-week table on this page converts each step into the exact amount to draw for your mix.
Three different points on the same pathway. NAD+ supplies the cofactor directly. MOTS-c is a mitochondrial-derived peptide studied for AMPK signalling. 5-Amino-1MQ inhibits NNMT, which is studied as a way of preserving the NAD+ salvage pathway rather than supplying NAD+ itself.
So one component adds the cofactor, one signals, and one slows its depletion. Of the blends here this has the most coherent mechanistic story — though as always, the case rests on the individual compounds rather than a trial of the combination.
Compounds in the same class, or browse the full catalogue.
An equal-parts repair and anti-inflammatory pairing — 10 mg of each in a 20 mg vial, so every dose splits evenly down the middle a…
A GHRH analogue paired with a selective ghrelin receptor agonist — the pairing rationale is that the two receptors act synergistic…
Every compound compared in one table: dose range, how often, half-life and evidence tier.
Need this on one page to print, screenshot or send?
Make a dose card →